Ra Capital Nexus Fund Ii, L.p. - Net Worth and Insider Trading

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .

In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.

Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in DICE Therapeutics Inc (DICE). Other recent insider transactions involving DICE Therapeutics Inc (DICE) include a net sale of 37,509 shares made by John R. Jacobsen , a net purchase of 1,007,701 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 2,492,871 shares made by Northpond Ventures Gp, Llc .

In summary, during the past 3 months, insiders sold 0 shares of DICE Therapeutics Inc (DICE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,666,925 shares of DICE Therapeutics Inc (DICE) were sold and 1,007,701 shares were bought by its insiders, resulting in a net sale of 1,659,224 shares.

DICE Therapeutics Inc (DICE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Eliem Therapeutics Inc (ELYM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eliem Therapeutics Inc (ELYM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eliem Therapeutics Inc (ELYM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 268,263 shares made by Adam K. Simpson , a net sale of 35,241 shares made by Cassia Cearley , and a net sale of 123,374 shares made by Niranjan Kanesa-thasan .

In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 514,269 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 514,269 shares.

Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Cytek Biosciences Inc (CTKB). Other recent insider transactions involving Cytek Biosciences Inc (CTKB) include a net sale of 323,889 shares made by Ming Yan , a net sale of 40,000 shares made by Patrick Jeanmonod , and a net sale of 240,000 shares made by Wenbin Jiang .

In summary, during the past 3 months, insiders sold 61,900 shares of Cytek Biosciences Inc (CTKB) in total and bought 0 shares, with a net sale of 61,900 shares. During the past 18 months, 603,889 shares of Cytek Biosciences Inc (CTKB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 603,889 shares.

Cytek Biosciences Inc (CTKB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 29,556 shares made by James G Mcarthur , a net sale of 6,392 shares made by Jaya Goyal , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 10,000 shares of PepGen Inc (PEPG) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 47,642 shares of PepGen Inc (PEPG) were sold and 2,559,287 shares were bought by its insiders, resulting in a net purchase of 2,511,645 shares.

PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Kabeer Aziz , a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , and a net sale of 10,000 shares made by Kevin Michael Krause .

In summary, during the past 3 months, insiders sold 0 shares of AN2 Therapeutics Inc (ANTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 565,631 shares of AN2 Therapeutics Inc (ANTX) were sold and 1,787,778 shares were bought by its insiders, resulting in a net purchase of 1,222,147 shares.

AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net sale of 7,965 shares made by Chione Ltd , and a net purchase of 2,353,000 shares made by Perceptive Life Sciences Master Fund Ltd .

In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 2,353,000 shares, with a net purchase of 2,353,000 shares. During the past 18 months, 7,965 shares of Acrivon Therapeutics Inc (ACRV) were sold and 2,353,000 shares were bought by its insiders, resulting in a net purchase of 2,345,035 shares.

Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 703,260 shares made by Sarina Tanimoto , a net sale of 703,260 shares made by Richard E Lowenthal , and a net sale of 543,896 shares made by Laura Shawver .

In summary, during the past 3 months, insiders sold 1,200,000 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 1,401,299 shares, with a net purchase of 201,299 shares. During the past 18 months, 1,950,416 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 8,937,557 shares were bought by its insiders, resulting in a net purchase of 6,987,141 shares.

ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ra Capital Nexus Fund Ii, L.p. made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 650,146 shares made by Avalon Ventures Xi, L.p. , a net sale of 650,146 shares made by Jay Lichter , and a net purchase of 27,133 shares made by Tighe Reardon .

In summary, during the past 3 months, insiders sold 3,822,721 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 3,822,721 shares. During the past 18 months, 3,822,721 shares of Janux Therapeutics Inc (JANX) were sold and 3,044,570 shares were bought by its insiders, resulting in a net sale of 778,151 shares.

Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.